Duodenogastric reflux and cancer

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 74-85

  Byrne, James P ^a   Attwood, Stephen E A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

DNA adduct levels; Duodenogastric reflux; Gastrointestinal tract

Indexed keywords

BILE ACID;

BARRETT ESOPHAGUS; CELL DAMAGE; DUODENOGASTRIC REFLUX; ESOPHAGUS CARCINOMA; PANCREAS JUICE; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; TISSUE INJURY;

ADENOCARCINOMA; ANIMALS; BARRETT ESOPHAGUS; CELL DIVISION; CHOLECYSTOKININ; DIET; DNA DAMAGE; DNA, NEOPLASM; DUODENOGASTRIC REFLUX; ESOPHAGEAL NEOPLASMS; GASTRECTOMY; HUMANS; STOMACH NEOPLASMS;

EID: 0032996579     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. 1 Bechi P, Pucciani F, Baldini F, et al: Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993; 38(7):1297-1306.
2. 2 Dyke GW, Craven JL, Hall R, Garner RC: DNA damage in the stomach after vagotomy measured by 32P-postlabelling. Gut 1993; 34(12):1683-1687.
3. 3 Suzuki K, Bruce WR: Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice. Journal of the National Cancer Institute 1986; 76(6):1129-1132.
4. 4 Russo P, Taningher M, Pala M, et al: Characterization of the effects induced on DNA in mouse and hamster cells by lithocholic acid. Cancer Research 1987; 47(11):2866-2874.
5. 5 Cheah PY, Bernstein H: Modification of DNA by bile acids: a possible factor in the etiology of colon cancer. Cancer Lett 1990; 49(3):207-210.
6. 6 Kulkarni MS, Cox BA, Yielding KL: Requirements for induction of DNA strand breaks by lithocholic acid. Cancer Research 1982; 42(7):2792-2795.
7. 7 Kandell RL, Bernstein C: Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutrition & Cancer 1991; 16(3-4):227-238.
8. 8 Attwood SEA ST, Marcus J, Murphy B, Stele P, DeMeester TR, Mirvish SS, Hinder RA: Effect of duodenal juice on DNA index and cell proliferation in a model of oesophageal carcinoma. Br J Surg 1991; 78(6):754.
9. 9 Gillen P, McDermott M, Grehan D, Hourihane DO, Hennessy TP: Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Br J Surg 1994; 81(12):1766-1768.
10. 10 Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH: Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. Journal of Pathology 1995; 175(2):175-180.
11. 11 Krishnadath KK, Tilanus HW, van Blankenstein M, et al: Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Research 1995; 55(9):1971-1976.
12. 12 Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK: Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2(8666):783-785.
13. 13 Scates DK, Spigelman AD, Phillips RK, Venitt S: DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis 1992; 13(4):731-735.
14. 14 Scates DK, Spigelman AD, Nugent KP, Phillips RK, Venitt S: DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis 1993; 14(6):1107-1110.
15. 15 Scates DK, Venitt S, Phillips RK, Spigelman AD: High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis. Gut 1995; 36(6):918-921.
16. 16 Garewal H, Bernstein H, Bernstein C, Sampliner R, Payne C: Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Research 1996; 56(7):1480-1483.
17. 17 Payne CM, Bernstein H, Bernstein C, Garewal H: Role of apoptosis in biology und pathology: resistance to apoptosis in colon carcinogenesis. Ultrastructural Pathology 1995; 19(4):221-248.
18. 18 Swami S, Kumble S, Triadafilopoulos G: E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 1995; 90(10):1808-1813.
19. 19 Salomoni M, Zuccato E, Granelli P, et al: Effect of bile salts on carbonic anhydrase from rat and human gastric mucosa. Scand J Gastroenterol 1989; 24(1):28-32.
20. 20 Domellof L, Reddy BS, Weisburger JH: Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy. Am J Surg 1980; 140(2):291-295.
21. 21 Kivilaakso E: Inhibition of gastric mucosal carbonic anhydrase by taurocholic acid and other ulcerogenic agents. American Journal of Surgery 1982; 144(5):554-557.
22. 22 Wenger J, Trowbridge CG: Bile and trypsin in the stomach following a test meal. Southern Medical Journal 1971; 64(9):1063-1064.
23. 23 Stoker DL WJ, Young RM, Billings JA, Chubb L, Colin Jones DG: Tryptic activity and bile in human oesophageal refluxate. Gullet 1991; 1:185-189.
24. 24 Mud HJ, Kranendonk SE, Obertop H, Van Houten H, Westbroek DL: Active trypsin and reflux oesophagitis: an experimental study in rats. Br J Surg 1982; 69(5):269-272.
25. 25 Kranendonk SE: Reflux oesophagitis. An experimental study in rats. Thesis, University of Rotterdam, 1980.
26. 26 Mason RC: Duodenogastric reflux in rat gastric carcinoma. Br J Surg 1986; 73(10):801-803.
27. 27 Pera M, Trastek VF, Carpenter HA, et al: Influence of pancreatic and biliary reflux on the development of esopbageal carcinoma. Annals of Thoracic Surgery 1993; 55(6):1386-1393.
28. 28 Champion G, Richter JE, Vaezi MF, Singh S, Alexander R: Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterol 1994; 107(3):747-754.
29. 29 Domellof L, Janunger KG: The risk for gastric carcinoma after partial gastrectomy. Am J Surg 1977; 134(5):581-584.
30. 30 Caygill CP, Hill MJ, Hall CN, Kirkham JS, Northfield TC: Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut 1987; 28(8):924-928.
31. 31 Lundegardh G, Adami HO, Helmick C, Zack M: Risk of cancer following partial gastrectomy for benign ulcer disease. Br J Surg 1994; 81(8):1164-1167.
32. 32 Moller H, Toftgaard C: Cancer occurrence in a cohort of patients surgically treated for peptic ulcer. Gut 1991; 32(7):740-744.
33. 33 Tersmette AC, Offerhaus GJ, Giardiello FM, Tersmette KW, Vandenbroucke JP, Tytgat GN: Occurrence of non-gastric cancer in the digestive tract after remote partial gastrectomy: analysis of an Amsterdam cohort. International Journal of Cancer 1990; 46(5):792-795.
34. 34 Taylor PR, Mason RC, Filipe MI, et al: Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index. Gut 1991; 32(12):1447-1454.
35. 35 Lehnert T, Deschner EE, Ivankovic S, DeCosse JJ: Promotion of gastric tumorigenesis by duodenal contents in rats induced with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Surgery 1988; 103(6):643-647.
36. 36 Houghton PW, Mortensen NJ, Williamson RC: Effect of duodenogastric reflux on gastric mucosal proliferation after gastric surgery. Br J Surg 1987; 74(4):288-291.
37. 37 Kuipers EJ, Uyterlinde AM, Pena AS, et al: Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345(8964):1525-1528.
38. 38 Ladas SD, Katsogridakis J, Malamou H, Giannopoulou H, Kesse-Elia M, Raptis SA: Helicobacter pylori may induce bile reflux: link between H. pylori and bile induced injury to gastric epithelium. Gut 1996; 38(1):15-18.
39. 39 Miwa K, Hattori T, Miyazaki I: Duodenogastric reflux and foregut carcinogenesis. Cancer 1995; 75(Suppl 6): 1426-1432.
40. 40 Miwa K, Segawa M, Takano Y, et al: Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 1994; 70(2):185-189.
41. 41 Caldwell MT, Lawlor P, Byrne PJ, Walsh TN, Hennessy TP: Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995; 82(5):657-660.
42. 42 Kauer WK, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy reemphasized. Ann Surg 1995; 222(4):525-533.
43. 43 Cardesa A, Bombi JA, Pera M, et al: Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy. Experimental & Toxicologic Pathology 1994; 46(1):41-49.
44. 44 Attwood SE, Smyrk TC, DeMeester TR, Mirvish SS, Stein HJ, Hinder RA: Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992; 111(5):503-510.
45. 45 Seto Y, Kobori O, Shimizu T, Morioka Y: The role of alkaline reflux in esophageal carcinogenesis induced by N-amyl-N-methylnitrosamine in rats. International Journal of Cancer 1991; 49(5):758-763.
46. 46 Pera M, Cardesa A, Bombi JA, Ernst H, Pera C, Mohr U: Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Research 1989; 49(23):6803-6808.
47. 47 Clark GW, Smyrk TC, Mirvish SS, et al: Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Annals of Surgical Oncology 1994; 1(3):252-261.
48. 48 Mirvish SS, Huang Q, Chen SC, et al: Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 1993; 25(9):627-631.
49. 49 Seto Y, Kobori O: Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus. Br J Surg 1993; 80(4):467-470.
50. 50 Bremner CG LV, Ellis FH Jr: Barrett's Oesophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970; 68:209-216.
51. 51 Gillen P, Keeling P, Byrne PJ, Healy M, RR OM, Hennessy TP: Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg 1988; 75(6):540-543.
52. 52 Attwood SE, Ball CS, Barlow AP, Jenkinson L, Norris TL, Watson A: Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus. Gut 1993; 34(1):11-15. (published erratum appears in Gut 1993 May; 34(5):716)
53. 53 Waring JP, Legrand J, Chinichian A, Sanowski RA: Duodenogastric reflux in patients with Barrett's esophagus. Dig Dis & Sci 1990; 35(6):759-762.
54. 54 Vaezi MF, Richter JE: Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117(6):699-704.
55. 55 Brown LM SC, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AB, Liff JM, Fraumeni JF, Hoover RN: adenocarcinoma of the oesophagus: Role of Obesity and Diet. Journal of the National Cancer Institute 1995; 87(2):104-109.
56. 56 Kabat GC, Ng SK, Wynder EL: Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes & Control 1993; 4(2):123-132.
57. 57 DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA: Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212(4):528-542.
58. 58 Walsh: Gastrin. In: GJ WJaD (Ed.). Gut Peptides. Raven Press, 1994.
59. 59 Ohning GV, Wong HC, Walsh JH: Differential kinetics for immunoneutralization of circulating gastrin by gastrin monoclonal antibody and its Fab1 fragment in rats. Peptides 1994; 15(3):417-423.
60. 60 Ishizuka J MJ, Townsend CM, Thompson JC: The effect of gastrin on growth of human stomach cancer cells. Ann Surg 1996; 215:528-534.
61. 61 Smith JP, Solomon TE: Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterol 1988; 95(6):1541-1548.
62. 62 Watson SA, Durrant LG, Morris DL: Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro. Br J Surg 1988; 75(4):342-345.
63. 63 Wang TC KT, Varro A, Cahill R, Dangler CA, Fox JG, Dockray GJ: Processing and proliferative effects of human progastrin in transgenic mice. Journal of Clinical Investigation 1996; 98:1918-1929.
64. 64 Kochmann ML DJ, Dickinson CJ, Boland CR: Post translational processing of gastrin in neoplastic human colonic tissue. Biochem Biophys Res Comm 1992; 189:1165-1169.
65. 65 Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF: Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterol 1993; 104(4):1099-1107.
66. 66 Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ: Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993; 34(1):90-95.
67. 67 Dockray GJ, Varro A, Dimaline R: Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiological Reviews 1996; 76(3):767-798.
68. 68 Seva C, Dickinson CJ, Yamada T: Growth-promoting effects of glycine-extended progastrin. Science 1994; 265(5170):410-412.
69. 69 Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A: Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterol 1995; 109(4):1142-1153.
70. 70 Watson SA, Michaeli D, Grimes S, et al: Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Research 1996; 56(4):880-885.
71. 71 Wong K, Beardshall K, Waters CM, Calam J, Poston GJ: Postprandial hypergastrinaemia in patients with colorectal cancer. Gut 1991; 32(11):1352-1354.
72. 72 Jankowski J, Hopwood D, Pringle R, Wormsley KG: Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Am J Gastroenterol 1993; 88(3):402-408.
73. 73 Nakamura R MK, Kuyama Y, Kitani K: Luminal bile regulates cholecystikinin release in conscious rats. Dig Dis & Sci 1990; 35(1):55-60.
74. 74 Taylor PR, Dowling RH, Palmer TJ, et al: Induction of pancreatic tumours by longterm duodenogastric reflux. Gut 1989; 30(11):1596-1600.
75. 75 Gasslander T, Mukaida H, Herrington MK, Hinder RA, Adrian TE: Profound duodenogastric reflux causes pancreatic growth in rats. Gut 1995; 36(1):137-141.
76. 76 Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr: The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274(6):474-477.